The predictive value of peripheral blood CD4 cells ATP concentration for immune-related adverse events in advanced non-small cell lung cancer patients
Lung cancer with the highest incidence and mortality in the world. Immune checkpoint inhibitors (ICIs), can bring long-term survival benefits to patients, but also can bring immune-related adverse events (irAE...
Source: BMC Immunology - Category: Allergy & Immunology Authors: Kailian Hou, Weipeng Ye, Qunfeng Huang, Weiyi Li, Zhiqiong Tan, Na tao, Dongheng yang, Haoxin Lin, Zihao Deng, Yuanyuan Xia and Guifang Yu Tags: Research Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer